Jump to content
ADVANCED CASE SEARCH
An affiliate of the U.S. Chamber of Commerce
Results are sorted by the date of most recent activity.
U.S. Chamber files amicus brief arguing that the Centers for Medicare and Medicaid Services lacks statutory authority to require pharmaceutical manufacturers to state the wholesale acquisition...
U.S. Chamber files amicus brief urging Third Circuit to grant petition for writ of mandamus and halt abusive discovery order requiring defendants to produce tens of millions of irrelevant,...
U.S. Chamber urges Tenth Circuit to hold that federal law preempts state-law claims challenging statements on a prescription drug’s label concerning the amount of the drug included in a vial.
U.S. Chamber leads coalition amicus brief in California Court of Appeal, arguing that a trade-secret owner may preclude the government from disclosing trade-secret information in response to a...
U.S. Supreme Court holds that judges, rather than juries, must decide whether federal prescription-drug regulations preempt state failure-to-warn claims. The Chamber urged the Court to take this...
En banc Ninth Circuit unanimously holds that San Francisco’s required health warnings for sugary drinks violate beverage makers’ constitutional free speech rights
Supreme Court declines to review circuit split on materiality under False Claims Act
U.S. Chamber files coalition amicus brief at merits stage, arguing Supreme Court should reverse Third Circuit’s mistaken approach to Wyeth v. Levine’s “clear evidence” standard
First Circuit affirms judgment that federal law preempts plaintiffs’ state-law claims against pharmaceutical companies’ refusal to alter size of eye-drop bottle
Seventh Circuit reverses $3 million verdict against GlaxoSmithKline, concluding plaintiffs’ negligent failure to warn claims were preempted by federal law